LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Jan 21, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-01-19

Reporting Person: Pecora Andrew L (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-19	Stock Options (right to buy)	$1.50	A	400000	Acquired	2021-01-18	Common Stock, par value $0.001 per share (400000)	Direct

Footnotes

F1: On January 19, 2011, the commencement date of his employment agreement with Progenitor Cell Therapy, LLC ("PCT"), a
wholly-owned subsidiary of NeoStem, Inc. (the "Company"), the reporting person was granted an option to purchase 400,000
shares of common stock, par value $0.001 per share, of the Company, pursuant and subject to the terms and conditions of the
Company's 2009 Equity Compensation Plan. This option is scheduled to vest as to 100,000 shares on each of January 19, 2012,
January 19, 2013, January 19, 2014 and January 19, 2015.